Myomo Inc
$ 1.42
8.40%
07 Aug - close price
- Market Cap 56,243,000 USD
- Current Price $ 1.42
- High / Low $ 1.44 / 1.25
- Stock P/E N/A
- Book Value 0.23
- EPS -0.34
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.23 %
- ROE -0.98 %
- 52 Week High 1.84
- 52 Week Low 0.60
About
Myomo, Inc., a portable medical robotics company, designs, develops and produces myoelectric braces for people with neuromuscular disorders in the United States. The company is headquartered in Boston, Massachusetts.
Analyst Target Price
$4.54
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-05 | 2026-05-07 | 2026-03-09 | 2025-11-10 | 2025-08-11 | 2025-05-07 | 2025-03-10 | 2024-11-06 | 2024-08-06 | 2024-05-08 | 2024-03-07 | 2023-11-07 |
| Reported EPS | -0.07 | -0.09 | -0.0852 | -0.09 | -0.11 | -0.08 | -0.01 | -0.03 | -0.03 | -0.1 | -0.07 | -0.06 |
| Estimated EPS | -0.1 | -0.11 | -0.084 | -0.11 | -0.11 | -0.08 | -0.0233 | -0.04 | -0.07 | -0.09 | -0.06 | -0.09 |
| Surprise | 0.03 | 0.02 | -0.0012 | 0.02 | 0 | 0 | 0.0133 | 0.01 | 0.04 | -0.01 | -0.01 | 0.03 |
| Surprise Percentage | 30% | 18.1818% | -1.4286% | 18.1818% | 0% | 0% | 57.0815% | 25% | 57.1429% | -11.1111% | -16.6667% | 33.3333% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MYO
2026-08-06 04:40:46
Myomo, Inc. reported strong second-quarter 2026 results, with revenue increasing 21% year-over-year to $11.7 million, driven by a shift to recurring patient sources and expanded market access. The company raised its full-year revenue guidance to $45-47 million and demonstrated significant operating leverage, improving Adjusted EBITDA by 79% compared to the prior year. Myomo continues to invest in product development and clinical research for its MyoPro product line.
2026-08-05 18:40:46
Myomo, Inc. (MYO) reported a Q2 loss of $0.07 per share, exceeding the Zacks Consensus Estimate of a $0.1 loss, marking a 30% surprise. The company also surpassed revenue estimates, posting $11.71 million against an expectation of $9.65 million. Despite outperforming the market year-to-date, Myomo currently holds a Zacks Rank #4 (Sell) due to unfavorable estimate revisions, suggesting potential underperformance in the near future.
2026-07-31 17:10:38
Myomo Inc. has appointed Joseph M. Manko Jr. to its Board of Directors, bringing the total number of directors to seven. Manko, a seasoned investment banker and senior principal of Horton Capital Management LLC, will serve until the 2027 annual meeting of stockholders. His extensive experience in capital markets, strategic planning, and corporate governance is expected to support Myomo's growth strategy and efforts to expand patient access for its MyoPro product line.
2026-07-30 05:41:41
Myomo, Inc. (NYSE American: MYO) announced it will report its second-quarter 2026 financial results on Wednesday, August 5, 2026. Management will host a conference call at 4:30 p.m. Eastern time to discuss the results and provide a business update, with webcast and dial-in replay options available. Myomo is a wearable medical robotics company specializing in devices for individuals with neurological disorders and upper-limb paralysis.
2026-07-30 03:10:47
Myomo will report its second-quarter 2026 financial results on August 5, 2026. The company will also host a conference call on the same day at 4:30 p.m. ET, with a webcast available on its investor relations website. This news brief was generated by Public Technologies using AI based on original content from Myomo Inc. via Business Wire.
2026-07-30 01:39:51
Myomo, Inc. (NYSE American: MYO) will announce its second quarter 2026 financial results on August 5, 2026, after the market closes. The company will also host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Investors can access the live webcast or dial in to participate.
